Statin use and pancreatic cancer risk in two prospective cohort studies

BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Gastroenterol
Huvudupphovsmän: Hamada, Tsuyoshi, Khalaf, Natalia, Yuan, Chen, Babic, Ana, Morales-Oyarvide, Vicente, Qian, Zhi Rong, Nowak, Jonathan A., Ng, Kimmie, Kraft, Peter, Rubinson, Douglas A., Stampfer, Meir J., Giovannucci, Edward L., Fuchs, Charles S., Ogino, Shuji, Wolpin, Brian M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609961/
https://ncbi.nlm.nih.gov/pubmed/29362938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1430-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk